Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 21 April 2027
- Last conf. stmt
- 7 April 2026
Dark Horse Technologies Ltd
- Incorporated
- 15 March 2018 (8 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Grant Alfred Cecil WhittleJared Bainbridge
- Accounts type
- Total exemption full
- Region
- South East
- Address
- C/o James Cowper KrestonWhite Building 1-4 Cumberland PlaceSouthamptonSO15 2NP
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Whittle, Grant Alfred Cecil
Director · Appointed 9 October 2021
American
Born December 1987 (38)
Bainbridge, Jared
Director · Appointed 15 March 2018
Australian
Born July 1985 (41)
Ownership 3 active
People and entities with significant control, from the Companies House PSC register
Private Limited Company
Reg. no. 15757714
Corporate entity · Notified 6 December 2023
Owns 25–50% of shares
Holds 25–50% of voting rights
Corporate
Reg. no. 09093331
Jared Bainbridge
Individual · Notified 15 March 2018
Holds 25–50% of voting rights
Australian
Born July 1985 (41)
Former controllers (1)
6 December 2023
Ceased Grant Whittle — Owns 25–50% of shares
Group structure 17 shown
Ownership group derived from the Companies House PSC register
Acionna Therapeutics Ltd Owns 50–75% of shares
Animal Dynamics Limited Owns 50–75% of shares
Archangel Lightworks Ltd Owns 25–50% of shares
Ascension Earth Resources Ltd Owns 25–50% of shares
Caudal Energy Limited Owns 25–50% of shares
Caudal Morlais Limited Owns 75–100% of shares
Circadian Therapeutics Limited Owns 75–100% of shares
Cora Biosciences Limited Owns 25–50% of shares
Credo Therapies Ltd Owns 50–75% of shares
Dark Horse Technologies Ltd This company In liquidationOwns 25–50% of shares
Densix Limited Owns 25–50% of shares
Dyna Therapeutics Limited Owns 50–75% of shares
Eligentis Limited Owns 25–50% of shares
Evox Therapeutics Limited Owns 25–50% of shares
Fluorok Limited Owns 25–50% of shares
Financials
Balance sheet as at 31 December 2025 · total exemption full accounts
- Net Assets
- (£398,994)
- Cash
- £10,086
- Debt Ratio
- 480%
- Current Ratio
- 26.9x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £0 | £37 | £1,835 | £3,422 | £870 | £1,885 |
| Current Assets | £104,906 | £846,179 | £722,856 | £1,225,144 | £273,269 | £9,100 |
| Debtors | £94,820 | £663,763 | £687,433 | £701,500 | £178,625 | |
| Cash | £10,086 | £182,416 | £35,423 | £523,644 | £94,644 | |
| Creditors (< 1 year) | £3,900 | £33,382 | £34,748 | £41,870 | £34,932 | |
| Creditors (> 1 year) | £500,000 | £500,000 | £0 | £1,000,000 | £0 | £15,000 |
| Net Current Assets | £101,006 | £812,797 | £688,108 | £1,183,274 | £238,337 | £9,100 |
| Net Assets | (£398,994) | £312,834 | £689,943 | £186,696 | £239,207 | (£4,015) |
| Shareholder Funds | (£398,994) | £312,834 | £689,943 | £186,696 | £239,207 | (£4,015) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 9 November 2026 | Registered office address changed | |||
| 6 August 2026 | Memorandum and Articles of Association | |||
| 6 August 2026 | Resolutions | |||
| 30 July 2026 | Termination of appointment of a director | |||
| 30 July 2026 | Notification of a person with significant control |
Other companies in this industry
Sandwich
Melbourn
London
Edinburgh
West Mains Road
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →